c="type IV OI" 2:15 2:17||t="problem"||cui="C0268363"||tot="Osteogenesis imperfecta type IV"||ns="-1000"
c="collagens" 2:50 2:50||t="treatment"||cui="C0009325"||tot="Collagen"||ns="-1000"
c="cyanogen bromide peptide CB 4-2" 2:60 2:64||t="test"||cui="C0010511"||tot="Cyanogen Bromide"||ns="-827"
c="Parental fibroblast collagens" 2:88 2:90||t="treatment"||cui="C0009325"||tot="Collagen"||ns="-827"
c="RNA-PCR" 2:143 2:143||t="test"||cui="C0032520"||tot="Polymerase Chain Reaction"||ns="-861"
c="two subcloned alleles" 2:152 2:154||t="test"||cui="C0002085"||tot="Alleles"||ns="-827"
c="DNA hybrid analysis" 2:208 2:210||t="test"||cui="C0200898"||tot="DNA analysis"||ns="-913"
